Clinical Trial Update: Study of SPARC1103 in Subjects With Spasticity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of SPARC1103 in subjects with spasticity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity

Drugs mentioned

• SPARC1103

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Spasticity | Phase 2 | Status: COMPLETED | Results posted: 2019-01-15